MongoDB (MDB) concentration risks

The company's disclosed concentration is product-driven and heavily weighted toward a single cloud offering: Atlas represented 73% of total revenue for the fiscal year ended January 31, 2026, up from 70% and 66% in the two prior years respectively. By disclosed size this is a high-share exposure, and the character is structural — Atlas is the company's cloud database-as-a-service platform, and the growing revenue share reflects a deliberate architectural and go-to-market strategy built around that offering. The upward trend in Atlas's revenue share over three consecutive years suggests the structural nature of this concentration is deepening rather than moderating. There are no disclosed customer, supplier, geographic, or regulatory concentrations alongside the product exposure. The risk profile is therefore predominantly tied to the growth trajectory and competitive standing of a single product. Because Atlas is consumption-based rather than purely subscription, revenue can contract if customer workloads shrink or if customers reduce consumption — a more dynamic risk than a fixed contract would imply, even if the underlying customer relationships remain intact. On balance, the disclosed profile is narrow and product-concentrated. The variables investors should monitor most closely are Atlas consumption growth rates, workload retention, and competitive pressure on the cloud database-as-a-service category, as these determine how the high-share product concentration translates into revenue outcomes quarter to quarter.

For the engine’s reasoning on MDB’s current verdict — including which dimensions drove the score — see the per-dimension breakdown.

Concentration counts reflect items disclosed in each peer’s most recent 10-K; disclosed-size classification uses TrendMatrix’s internal 10-K extraction taxonomy.